glp-1 news As Drugs Go Mainstream, This Expert Says Health is More than a Number on a Scale News Brief: FDA Seeks Removal

At 52 weeks, a reduction in circulating volume and blood pressure is observed, associated with decreased levels of adipokines and aldosterone, alongside reduced albuminuria and increased glomerular filtration rate compared with placebo, suggesting an additional renal benefit.47 GIP antagonist - GLP-1 agonist: MariTida This drug (Maridebart-cafraglutide or AMG 133), which is a conjugate of a monoclonal antibody to the GIP receptor and two GLP-1 receptor agonist molecules, is effective in reducing body weight in obese mice and cynomolgus monkeys

The findings identified Comp68, Comp70, and Comp71 as promising DPP4is with high selectivity scores and favorable MD total energies

This distinction matters not just to drug developers, but to the broader drug manufacturing market: as peptide drug volumes scale, demand surges for the reagents, instrumentation, contract manufacturing capacity, and analytical workflows that underpin both approaches

GLP-1 [37]

So, maybe some of these uses will end up being good, but we need to study them first. Further study is also necessary for potential long-term adverse events